Ophthotech Corp Logo Image

Ophthotech Corp

Ophthotech Corp Banner Image

Ophthotech Corp has reached its limit for report views.

Please check back to see if Ophthotech Corp has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2015 Annual Report and Form 10K

Ophthotech Corp

Ophthotech Corp does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • Ophthotech Corp
  • Ophthotech Corp

About Ophthotech Corp

51-200 Employees
Based in New York, New York

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of back of the eye. Its principal product candidate, Fovista, is in Phase III clinical development for use in combination with anti-VEGF drugs for the treatment of wet age-related macular degeneration (AMD).

Ticker:
OPHT
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol